Fortrea Holdings (FTRE) Short term Debt (2023 - 2026)
Fortrea Holdings (FTRE) reported Short term Debt of $10.9 million for Q1 2026, down 93.35% on a YoY basis from $163.8 million in Q1 2025, and up 127.08% quarter-over-quarter from $4.8 million in Q4 2025.
Fortrea Holdings (FTRE) Short term Debt (2023 - 2026) Analysis & Trends
Fortrea Holdings has reported Short term Debt for 4 years, with the latest figure at $10.9 million in Q1 2026.
- For the quarter ending Q1 2026, Short term Debt fell 93.35% year-over-year to $10.9 million; the trailing twelve-month figure through Mar 2026 stood at $10.9 million (down 93.35% YoY), and the FY2025 full-year result was $4.8 million, down 93.58% from the prior year.
- Short term Debt for Q1 2026 stood at $10.9 million, up from $4.8 million in the prior quarter.
- The five-year high for Short term Debt was $163.8 million in Q1 2025, with the low at $4.8 million in Q4 2025.
- Historically, Short term Debt has averaged $53.7 million across 4 years, with a median of $40.6 million in 2023.
- The largest YoY upside for Short term Debt was 197.82% in 2025 against a maximum downside of 93.58% in 2025.
- Fortrea Holdings' Short term Debt stood at $26.1 million in 2023, then jumped by 186.59% to $74.8 million in 2024, then plunged by 93.58% to $4.8 million in 2025, then surged by 127.08% to $10.9 million in 2026.
- The last three Short term Debt figures came in at $10.9 million (Q1 2026), $4.8 million (Q4 2025), and $74.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.90 Mn |
| Dec 31, 2025 | 4.80 Mn |
| Sep 30, 2025 | 74.50 Mn |
| Jun 30, 2025 | 74.80 Mn |
| Mar 31, 2025 | 163.80 Mn |
| Dec 31, 2024 | 74.80 Mn |
| Mar 31, 2024 | 55.00 Mn |
| Dec 31, 2023 | 26.10 Mn |
| Sep 30, 2023 | 26.10 Mn |
| Jun 30, 2023 | 26.10 Mn |